Pfizer, BioNTech Boost Supply Agreement With Turkey
20 Mayo 2021 - 5:51AM
Noticias Dow Jones
By Matt Grossman
Pfizer Inc. and BioNTech SE have reached an agreement to expand
the supply of their Covid-19 vaccine to Turkey, the companies said
Thursday.
The pharmaceutical companies behind the first Covid-19 vaccine
that was authorized for use in the U.S. late last year said they
will supply 60 million additional doses of their vaccine to Turkey,
with an option for 30 million additional doses.
In December, the companies had agreed to supply Turkey with 30
million doses. The new agreement brings the total number of doses
to be supplied to Turkey to 120 million.
The companies said they plan to have all the doses available
this year for Turkey, which has a population of more than 80
million. Two doses of the vaccine are administered to each
person.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
May 20, 2021 06:36 ET (10:36 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
BioNTech (NASDAQ:BNTX)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
BioNTech (NASDAQ:BNTX)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
